Stoke Therapeutics, Inc. (FRA:0GT)

Stoke Therapeutics Revenue

Stoke Therapeutics had revenue of $10.63M USD in the quarter ending September 30, 2025, with 117.25% growth. This brings the company's revenue in the last twelve months to $205.63M, up 1,128.17% year-over-year. In the year 2024, Stoke Therapeutics had annual revenue of $36.56M with 316.34% growth.

• Revenue (ttm): $205.63M
• Revenue Growth: +1,128.17%
• P/S Ratio: 8.32
• Revenue / Employee: $1.61M
• Employees: 128
• Market Cap: 1.46B EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	36.56M	27.78M	316.34%
Dec 31, 2023	8.78M	-3.63M	-29.22%
Dec 31, 2022	12.41M	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-